Biotech

All Articles

Daiichi spends Merck $170M to develop lung cancer cells T-cell engager treaty

.Merck &amp Co. has rapidly gotten back some of the expenses of its Harp on Therapeutics buyout, att...

BioMarin stops preclinical gene treatment for heart disease

.After BioMarin performed a spring season tidy of its own pipe in April, the business has actually d...

Eisai plants molecular glue SEED along with $1.5 B biobucks work

.Significant Pharmas remain stuck to the suggestion of molecular glue degraders. The latest company ...

Life science debt firm reveals with $600M

.A brand new worldwide life scientific research debt company, dubbed Symbiotic Resources, has actual...

BMS ditches TIGIT, ignoring $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing one more major bet from the Caforio time, canceling a packag...

Nuvation stops wager prevention after considering period 1 information

.After having a look at period 1 data, Nuvation Biography has actually chosen to stop work on its ow...

' Clinical intuitiveness' led FDA specialists to support Zevra's rare disease med

.Zevra Therapeutics' unusual health condition drug seems to be to become on the road to confirmation...

Pfizer takes $230M attacked after axing failed DMD genetics therapy

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) gene treatment failure has gone a $230 thousand op...

AC Immune finds 'site' possible in Alzheimer's medication data

.After greater than two decades of work with neurodegenerative health conditions, Swiss biotech AC I...

GSK falls ph. 2 HPV injection over absence of best-in-class possible

.GSK has actually junked a phase 2 individual papillomavirus (HPV) injection from its pipeline after...